Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/03/15 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
31 | |
| 09/02/15 | 8-K | Current report filing |
|
11 | |
| 08/26/15 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses |
|
16 | |
| 08/25/15 | 8-K | Current report filing |
|
22 | |
| 08/21/15 | 8-K | Current report filing |
|
8 | |
| 08/20/15 | 8-K | Current report filing |
|
8 | |
| 08/18/15 | 8-K | Current report filing |
|
4 | |
| 08/17/15 | 8-K | Current report filing |
|
13 | |
| 08/14/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
52 |
| 08/13/15 | 8-K | Current report filing |
|
4 |
